| Literature DB >> 34836268 |
Hugo J Bello1, Alberto Caballero-García2, Daniel Pérez-Valdecantos3, Enrique Roche4,5,6, David C Noriega7, Alfredo Córdova-Martínez3.
Abstract
Vitamin D is a key micronutrient modulating function and health in skeletal muscle. Therefore, we sought to systematically review the role of vitamin D in muscle recovery. A search in different databases (PubMed/MEDLINE, WOS, Google Scholar, and Scopus) was carried out following PRISMA® and PICOS. The search period was from inception to April 2020. Changes in post-exercise muscle damage were quantified comparing experimental group vs. placebo in each study by using number of participants, standardized mean difference (SMD), and standard error of the SMD. Hedges's g was used to calculate the SMDs for each study group and biased by the inverse of variance that allows calculating an overall effect and the 95% confidence interval (CI). The net vitamin D supplementation effect was calculated by subtracting the placebo SMD from SMD of the experimental group. The DerSimonian and Laird method was used as a random effect model, taking into account that the effect of vitamin D on muscular damage may vary according to the dose administered and additional moderators. Six studies were selected. In conclusion, regarding circulating levels of muscle biomarkers and additional limitations of the studies, it cannot be concluded that vitamin D supplementation exerts an effect in post-exercise muscle recovery. Likely, the anti-inflammatory action of vitamin D is quicker than the recovery of tissue structure and function. This aspect is pending verification in future research.Entities:
Keywords: creatine kinase; exercise; muscle damage; myoglobin; recovery; vitamin D
Mesh:
Substances:
Year: 2021 PMID: 34836268 PMCID: PMC8619231 DOI: 10.3390/nu13114013
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Bias risk of different aspects for the selected studies.
| Study | Randomized | Blinding of Participants | Blinding of Outcome Assessment |
|---|---|---|---|
| Nieman et al., 2013 [ | + | + | + |
| Shanely et al., 2014 [ | + | + | + |
| Parsaie et al., 2019 [ | + | + | + |
| Ashtary-Larky et al., 2020 [ | + | + | + |
| Pilch et al., 2020 [ | + | − | − |
| Żebrowska et al., 2020 [ | − | + | + |
(+) indicates low bias risk and (−) indicates high bias risk.
Figure 1Flow chart of the process of study selection.
General characteristics of the selected studies.
|
| Young men/High school | 2 studies: Pilch et al., 2020 [ |
| Resistance-trained men/Male runners | 2 studies: Ashtary-Larky et al., 2020 [ | |
| Male soccer players | 1 study: Parsaie et al., 2019 [ | |
| NASCAR pit crew | 1 study: Nieman et al., 2013 [ | |
|
| <20 years old | 1 study: Shanely et al., 2014 [ |
| 20–30 years old | 4 studies: Nieman et al., 2013 [ | |
| 30–40 years old | 1 study: Żebrowska et al., 2020 [ | |
|
| Ingestion | 5 studies: Nieman et al., 2013 [ |
| Injection | 1 study: Ashtary-Larky et al., 2020 [ | |
|
| 600 IU/day | 1 study: Shanely et al., 2014 [ |
| 2000 IU/week | 1 study: Żebrowska et al., 2020 [ | |
| 3800 IU/day | 1 study: Nieman et al., 2013 [ | |
| 50,000 IU/day | 1 study: Parsaie et al., 2019 [ | |
| 300,000 IU injected in one dose | 1 study: Ashtary-Larky et al., 2020 [ | |
| Calculated from participant’s body mass using Singh and Bonham formula | 1 study: Pilch et al., 2020 [ | |
|
| 3 weeks | 1 study: Żebrowska et al., 2020 [ |
| 4 weeks | 1 study: Ashtary-Larky et al., 2020 [ | |
| 6 weeks | 2 studies: Nieman et al., 2013 [ | |
| 8 weeks | 1 study: Parsaie et al., 2019 [ | |
| 12 weeks | 1 study: Pilch et al., 2020 [ | |
|
| Eccentric exercise | 3 studies: Nieman et al., 2013 [ |
| Loughborough intermittent shuttle test | 2 studies: Parsaie et al., 2019 [ | |
| Acute resistance exercise (different presses and weights) | 1 study: Ashtary-Larky et al., 2020 [ |
Abbreviations used: IU, international units; VitD2, ergocalciferol; VitD3, cholecalciferol.
Supplementation protocols.
| Study | Circulating Vitamin D Levels (ng/mL) before the Study | Dose (IU) | Extent |
|---|---|---|---|
| Nieman et al., 2013 [ | 39 ± 2 (Experimental group *) | 3800 IU/day | 6 weeks |
| Shanely et al., 2014 [ | 25 ± 2 (Experimental group *) | 600 IU/day | 6 weeks |
| Parsaie et al., 2019 [ | 14 (Experimental group *) | 50,000 IU/week | 8 weeks |
| Ashtary-Larky et al., 2020 [ | 14 ± 3.9 (Experimental group *) | 300,000 IU injected | 4 weeks |
| Pilch et al., 2020 [ | 30.5 ± 0.34 (OE group: Optimal levels of vitamin D at the beginning and supplemented during the intervention) | Calculated from participant’s body mass using Singh and Bonham formula. | 12 weeks |
| Żebrowska et al., 2020 [ | 40 ± 8.8 (Experimental group *) | 2000 IU/day | 3 weeks |
(*) The experimental groups consume the corresponding dose of vitamin D indicated in the next column (“Dose (IU)”). Abbreviations used: IU, international units.
Figure 2Forest plot comparing the effects of vitamin D supplementation on circulating CK levels after exercise. The squares in the forest plot on the left side of the line represent studies or groups in which the mean of the experimental group (supplemented) was lower than the mean of the control group (placebo). The ones in the right side indicate the opposite.
Figure 3Forest plot comparing the effects of vitamin D supplementation on circulating LDH levels after exercise. The squares in the forest plot on the left side of the line represent studies or groups in which the mean of the experimental group (supplemented) was lower than the mean of the control group (placebo). The ones in the right side indicate the opposite.
Figure 4Forest plot comparing the effects of vitamin D supplementation on circulating Mb levels after exercise. The squares in the forest plot on the left side of the line represent studies or groups in which the mean of the experimental group (supplemented) was lower than the mean of the control group (placebo). The ones in the right side indicate the opposite.
Sample size (participants) and main outcomes of the different studies.
| Study | Sample Size | Analyzed Parameters | Main Outcomes |
|---|---|---|---|
| Nieman et al., 2013 [ | 28 | CK, LDH, Mb | |
| Shanely et al., 2014 [ | 50 | CK, LDH, Mb | =CK, =LDH, =Mb |
| Parsaie et al., 2019 [ | 22 | CK, LDH | =CK, =LDH |
| Ashtary-Larky et al., 2020 [ | 14 | CK, LDH | =CK, =LDH |
| Pilch et al., 2020 [ | 60 | CK, LDH, Mb | |
| Żebrowska et al., 2020 [ | 24 | CK, LDH, Mb |
Abbreviations and symbols used: CK, creatine kinase; LDH, lactate dehydrogenase; Mb, myoglobin, (↑) significant increased levels after intervention (negative outcome) in the supplemented group compared to placebo), (↓) significant decreased levels after intervention (positive outcome) in the supplemented group compared to the placebo group, (=) not significant differences after the intervention comparing experimental group to placebo. (*) Observed after 3 months of supplementation in the group with suboptimal levels of circulating vitamin D at the beginning of the study compared to a non-supplemented group. Articles include other outcomes not presented in the table.
The main limitations of the different studies of the meta-analysis.
| Study | Limitations |
|---|---|
| Nieman et al., 2013 [ | Physical activity consists in a very specific job, difficult to compare with other sport disciplines. |
| Shanely et al., 2014 [ | Information regarding the physical activity performed is limited, being complicated the comparison with other studies. |
| Parsaie et al., 2019 [ | Analytical method for vitamin D determination: immunoassay. |
| Ashtary-Larky et al., 2020 [ | The exact type of endurance activity is not indicated. |
| Pilch et al., 2020 [ | Subjective control of the physical activity performed. |
| Żebrowska et al., 2020 [ | Analytical method for vitamin D determination: no indicated. |